Preformed Line Products (PLPC) Financials

$143.02 -3.77 (-2.57%)

Closing price 03:59 PM Eastern

Extended Trading

$142.82 -0.20 (-0.14%)

As of 04:04 PM Eastern

Annual Income Statements for Preformed Line Products

This table shows Preformed Line Products' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	37	63	54
Consolidated Net Income / (Loss)	37	63	54
Net Income / (Loss) Continuing Operations	37	63	54
Total Pre-Tax Income	51	82	74
Total Operating Income	51	84	69
Total Gross Profit	190	235	215
Total Revenue	594	670	637
Operating Revenue	594	670	637
Total Cost of Revenue	404	435	422
Operating Cost of Revenue	404	435	422
Total Operating Expenses	139	151	146
Selling, General & Admin Expense	67	75	70
Marketing Expense	49	51	46
Research & Development Expense	22	22	20
Other Operating Expenses / (Income)	0.93	2.49	3.60
Impairment Charge	0.00	0.00	6.53
Total Other Income / (Expense), net	0.01	-1.81	4.34
Interest Expense	2.22	3.91	3.21
Interest & Investment Income	2.57	1.81	0.63
Other Income / (Expense), net	-0.34	0.28	6.93
Income Tax Expense	14	19	19
Net Income / (Loss) Attributable to Noncontrolling Interest	0.02	0.01	0.00
Basic Earnings per Share	$7.56	$12.87	$11.03
Weighted Average Basic Shares Outstanding	4.91M	4.92M	4.93M
Diluted Earnings per Share	$7.50	$12.68	$10.88
Weighted Average Diluted Shares Outstanding	4.95M	5.00M	5.00M
Weighted Average Basic & Diluted Shares Outstanding	4.94M	4.90M	4.92M
Cash Dividends to Common per Share	$0.80	$0.80	$0.80

This table shows Preformed Line Products' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	10	7.68	9.37	9.60	6.33	15	20	21	17	12
Consolidated Net Income / (Loss)	10	7.70	9.37	9.60	6.31	15	20	21	16	12
Net Income / (Loss) Continuing Operations	10	7.70	9.37	9.60	6.31	15	20	21	16	12
Total Pre-Tax Income	17	10	11	12	6.97	20	28	28	24	18
Total Operating Income	18	10	11	12	6.95	20	28	29	25	17
Total Gross Profit	56	46	44	44	48	54	66	66	62	58
Total Revenue	167	147	139	141	146	160	182	182	170	165
Operating Revenue	167	147	139	141	146	160	182	182	170	165
Total Cost of Revenue	111	101	94	97	98	106	115	116	108	107
Operating Cost of Revenue	111	101	94	97	98	106	115	116	108	107
Total Operating Expenses	38	35	33	33	41	34	38	37	38	41
Selling, General & Admin Expense	19	16	15	17	20	18	18	19	20	17
Marketing Expense	13	12	12	12	13	13	13	12	12	11
Research & Development Expense	5.59	5.55	5.36	5.43	5.69	5.84	5.76	5.19	4.78	4.74
Other Operating Expenses / (Income)	0.75	1.11	0.45	-1.37	2.50	-2.31	1.19	1.11	1.13	0.94
Total Other Income / (Expense), net	-0.19	0.04	-0.13	0.30	0.02	-0.50	-0.61	-0.72	-0.38	0.22
Interest Expense	0.38	0.56	0.57	0.71	0.71	1.00	1.13	1.07	1.09	0.82
Interest & Investment Income	0.72	0.54	0.35	0.97	0.61	0.48	0.42	0.30	0.27	0.14
Other Income / (Expense), net	-0.53	0.06	0.09	0.04	0.12	0.02	0.11	0.04	0.43	0.90
Income Tax Expense	6.88	2.73	1.79	2.26	0.66	4.43	7.08	6.84	7.72	5.71
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.01	0.02	0.00	0.01	-0.02	0.02	-0.01	0.02	-0.02	0.00
Basic Earnings per Share	$2.13	$1.57	$1.91	$1.95	$1.32	$3.08	$4.14	$4.33	$3.35	$2.41
Weighted Average Basic Shares Outstanding	4.91M	4.90M	4.92M	4.92M	4.92M	4.91M	4.94M	4.94M	4.93M	4.94M
Diluted Earnings per Share	$2.13	$1.54	$1.89	$1.94	$1.29	$3.03	$4.08	$4.28	$3.26	$2.36
Weighted Average Diluted Shares Outstanding	4.95M	4.98M	4.96M	4.94M	5.00M	4.99M	5.02M	5.00M	5.00M	5.04M
Weighted Average Basic & Diluted Shares Outstanding	4.94M	4.90M	4.91M	4.92M	4.90M	4.89M	4.92M	4.95M	4.92M	4.92M

This table details how cash moves in and out of Preformed Line Products' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	3.64	16	0.83
Net Cash From Operating Activities	67	108	26
Net Cash From Continuing Operating Activities	67	108	26
Net Income / (Loss) Continuing Operations	37	63	54
Consolidated Net Income / (Loss)	37	63	54
Depreciation Expense	21	19	16
Non-Cash Adjustments To Reconcile Net Income	6.12	14	12
Changes in Operating Assets and Liabilities, net	3.42	11	-56
Net Cash From Investing Activities	-12	-45	-47
Net Cash From Continuing Investing Activities	-12	-45	-47
Purchase of Property, Plant & Equipment	-15	-35	-41
Acquisitions	0.00	-12	-16
Purchase of Investments	-3.15	0.00	0.00
Sale of Property, Plant & Equipment	3.45	2.63	3.17
Sale and/or Maturity of Investments	1.99	0.00	0.00
Other Investing Activities, net	0.00	0.00	6.91
Net Cash From Financing Activities	-48	-49	23
Net Cash From Continuing Financing Activities	-48	-49	23
Repayment of Debt	-132	-197	-154
Repurchase of Common Equity	-8.61	-19	-5.47
Payment of Dividends	-4.08	-4.11	-4.10
Issuance of Debt	96	169	185
Issuance of Common Equity	0.21	2.16	0.81
Other Net Changes in Cash	-3.68	2.44	-1.11

This table details how cash moves in and out of Preformed Line Products' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	9.75	0.07	1.57	-7.75	9.87	0.58	11	-5.45	6.29	0.85
Net Cash From Operating Activities	24	9.37	28	5.75	19	43	20	25	17	15
Net Cash From Continuing Operating Activities	24	9.37	28	5.75	19	43	20	25	17	15
Net Income / (Loss) Continuing Operations	10	7.70	9.37	9.60	6.31	15	20	21	16	12
Consolidated Net Income / (Loss)	10	7.70	9.37	9.60	6.31	15	20	21	16	12
Depreciation Expense	4.85	5.32	5.25	5.41	5.31	4.64	4.69	4.28	6.24	3.31
Non-Cash Adjustments To Reconcile Net Income	5.11	1.08	0.16	-0.23	6.58	0.92	3.91	3.02	5.66	7.40
Changes in Operating Assets and Liabilities, net	3.67	-4.73	14	-9.03	1.09	22	-8.64	-3.29	-11	-7.30
Net Cash From Investing Activities	-4.63	-3.45	-3.60	-0.68	-8.09	-7.56	-6.84	-22	-19	-11
Net Cash From Continuing Investing Activities	-4.63	-3.45	-3.60	-0.68	-8.09	-7.56	-6.84	-22	-19	-11
Purchase of Property, Plant & Equipment	-3.43	-3.57	-3.73	-3.92	-8.21	-9.94	-8.83	-8.35	-15	-11
Sale of Property, Plant & Equipment	-0.04	0.13	0.13	3.24	0.13	2.38	0.01	0.12	0.01	-
Net Cash From Financing Activities	-7.00	-7.30	-22	-12	-3.38	-34	-2.36	-9.31	7.90	-0.88
Net Cash From Continuing Financing Activities	-7.00	-7.30	-22	-12	-3.38	-34	-2.36	-9.31	7.90	-0.88
Repayment of Debt	-8.11	-45	-45	-38	-46	-46	-49	-55	-48	-41
Repurchase of Common Equity	-0.35	-2.23	-0.57	-5.45	-0.49	-8.56	-6.10	-3.74	-1.53	-2.14
Payment of Dividends	-0.98	-0.98	-0.98	-1.13	-0.98	-0.98	-0.99	-1.15	-1.01	-1.02
Issuance of Debt	2.39	41	25	33	44	21	54	50	58	43
Issuance of Common Equity	0.05	0.10	0.00	0.06	0.14	1.36	0.31	0.36	0.33	0.36
Other Net Changes in Cash	-2.69	-	-	-1.15	-	-	-	-	-	-

This table presents Preformed Line Products' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	574	603	568
Total Current Assets	316	325	328
Restricted Cash	57	54	37
Accounts Receivable	111	107	125
Inventories, net	130	149	147
Prepaid Expenses	12	8.25	13
Other Current Assets	5.51	7.26	4.93
Plant, Property, & Equipment, net	195	208	175
Total Noncurrent Assets	63	70	65
Goodwill	27	29	28
Intangible Assets	9.66	13	14
Noncurrent Deferred & Refundable Income Taxes	6.55	7.11	5.32
Other Noncurrent Operating Assets	20	21	18
Total Liabilities & Shareholders' Equity	574	603	568
Total Liabilities	152	187	210
Total Current Liabilities	108	111	115
Short-Term Debt	10	13	21
Accounts Payable	42	38	47
Accrued Expenses	26	27	18
Dividends Payable	1.29	1.30	1.32
Current Deferred & Payable Income Tax Liabilities	1.96	1.67	2.47
Current Employee Benefit Liabilities	26	28	24
Other Current Liabilities	1.59	1.67	1.61
Total Noncurrent Liabilities	43	76	95
Long-Term Debt	18	49	68
Noncurrent Deferred & Payable Income Tax Liabilities	3.77	3.54	4.17
Other Noncurrent Operating Liabilities	21	23	22
Total Equity & Noncontrolling Interests	422	416	359
Total Preferred & Common Equity	422	416	359
Total Common Equity	422	416	359
Common Stock	79	75	67
Retained Earnings	553	520	461
Treasury Stock	-127	-118	-99
Accumulated Other Comprehensive Income / (Loss)	-83	-60	-70
Other Equity Adjustments	0.00	0.00	0.00
Noncontrolling Interest	0.01	-0.01	-0.01

This table presents Preformed Line Products' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	592	573	586	607	622	602	531
Total Current Assets	321	305	314	338	353	339	308
Restricted Cash	47	-	46	44	43	32	-
Accounts Receivable	111	101	112	126	145	141	123
Inventories, net	143	142	142	150	148	150	135
Prepaid Expenses	13	7.39	8.31	8.33	8.75	8.30	-
Other Current Assets	6.48	6.98	7.05	10	8.44	8.18	3.25
Plant, Property, & Equipment, net	201	200	203	201	200	196	160
Total Noncurrent Assets	70	67	69	67	68	67	63
Goodwill	29	28	29	28	30	29	26
Intangible Assets	11	11	12	13	14	14	14
Noncurrent Deferred & Refundable Income Taxes	9.50	7.72	7.38	6.93	6.42	6.15	5.90
Other Noncurrent Operating Assets	21	20	21	19	18	17	17
Total Liabilities & Shareholders' Equity	592	573	586	607	622	602	531
Total Liabilities	163	156	173	207	223	222	200
Total Current Liabilities	114	104	100	136	127	125	120
Short-Term Debt	11	9.75	8.57	18	21	17	21
Accounts Payable	42	43	42	51	50	56	48
Accrued Expenses	26	23	21	27	23	19	18
Dividends Payable	1.26	1.22	1.19	1.26	1.23	1.19	1.28
Current Deferred & Payable Income Tax Liabilities	2.35	1.53	2.36	6.76	5.79	7.80	2.36
Current Employee Benefit Liabilities	29	24	23	30	25	22	28
Other Current Liabilities	1.61	1.56	1.53	1.63	1.19	1.54	1.64
Total Noncurrent Liabilities	49	52	73	71	97	96	79
Long-Term Debt	25	29	48	45	69	68	56
Capital Lease Obligations	6.99	-	7.39	7.91	-	7.11	6.33
Noncurrent Deferred & Payable Income Tax Liabilities	2.84	2.21	3.41	2.98	3.31	3.51	3.86
Other Noncurrent Operating Liabilities	15	21	14	15	24	17	13
Total Equity & Noncontrolling Interests	429	416	413	400	398	381	331
Total Preferred & Common Equity	429	416	413	400	398	381	331
Total Common Equity	429	416	413	400	398	381	331
Common Stock	77	76	75	73	70	68	65
Retained Earnings	544	537	529	515	501	481	445
Treasury Stock	-127	-124	-124	-118	-109	-103	-98
Accumulated Other Comprehensive Income / (Loss)	-65	-73	-67	-70	-64	-66	-82
Other Equity Adjustments	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Noncontrolling Interest	0.02	0.00	-0.00	0.02	0.00	0.01	0.01

This table displays calculated financial ratios and metrics derived from Preformed Line Products' official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	-11.34%	5.13%	23.12%
EBITDA Growth	-31.06%	11.47%	39.82%
EBIT Growth	-40.29%	10.68%	50.32%
NOPAT Growth	-42.68%	26.44%	47.37%
Net Income Growth	-41.41%	16.43%	52.29%
EPS Growth	-40.85%	16.54%	51.32%
Operating Cash Flow Growth	-37.31%	311.59%	-22.16%
Free Cash Flow Firm Growth	34.18%	348.59%	-1,116.58%
Invested Capital Growth	-7.31%	3.36%	21.04%
Revenue Q/Q Growth	3.76%	-3.50%	6.43%
EBITDA Q/Q Growth	15.30%	-15.45%	17.54%
EBIT Q/Q Growth	24.50%	-17.53%	19.78%
NOPAT Q/Q Growth	13.15%	-13.87%	20.47%
Net Income Q/Q Growth	12.54%	-13.85%	16.09%
EPS Q/Q Growth	12.61%	-13.45%	15.62%
Operating Cash Flow Q/Q Growth	7.62%	2.14%	40.35%
Free Cash Flow Firm Q/Q Growth	89.88%	60.18%	-182.29%
Invested Capital Q/Q Growth	-7.06%	-0.47%	7.16%
Profitability Metrics	-	-	-
Gross Margin	31.97%	35.07%	33.78%
EBITDA Margin	12.00%	15.43%	14.55%
Operating Margin	8.55%	12.57%	10.89%
EBIT Margin	8.49%	12.61%	11.98%
Profit (Net Income) Margin	6.25%	9.46%	8.54%
Tax Burden Percent	73.10%	76.92%	73.81%
Interest Burden Percent	100.70%	97.52%	96.61%
Effective Tax Rate	26.90%	23.08%	26.19%
Return on Invested Capital (ROIC)	9.04%	15.44%	13.60%
ROIC Less NNEP Spread (ROIC-NNEP)	8.93%	11.06%	21.81%
Return on Net Nonoperating Assets (RNNOA)	-0.19%	0.91%	2.52%
Return on Equity (ROE)	8.85%	16.35%	16.12%
Cash Return on Invested Capital (CROIC)	16.63%	12.14%	-5.44%
Operating Return on Assets (OROA)	8.57%	14.41%	14.43%
Return on Assets (ROA)	6.31%	10.81%	10.29%
Return on Common Equity (ROCE)	8.85%	16.35%	16.13%
Return on Equity Simple (ROE_SIMPLE)	8.79%	15.22%	15.17%
Net Operating Profit after Tax (NOPAT)	37	65	51
NOPAT Margin	6.25%	9.67%	8.04%
Net Nonoperating Expense Percent (NNEP)	0.11%	4.38%	-8.21%
Return On Investment Capital (ROIC_SIMPLE)	8.23%	13.53%	11.42%
Cost of Revenue to Revenue	68.03%	64.93%	66.22%
SG&A Expenses to Revenue	11.37%	11.15%	11.04%
R&D to Revenue	3.69%	3.36%	3.09%
Operating Expenses to Revenue	23.42%	22.50%	22.89%
Earnings before Interest and Taxes (EBIT)	50	84	76
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	71	103	93
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.48	1.56	1.13
Price to Tangible Book Value (P/TBV)	1.62	1.74	1.28
Price to Revenue (P/Rev)	1.05	0.97	0.63
Price to Earnings (P/E)	16.85	10.26	7.43
Dividend Yield	0.63%	0.60%	0.97%
Earnings Yield	5.94%	9.74%	13.47%
Enterprise Value to Invested Capital (EV/IC)	1.51	1.55	1.11
Enterprise Value to Revenue (EV/Rev)	1.00	0.98	0.72
Enterprise Value to EBITDA (EV/EBITDA)	8.37	6.37	4.92
Enterprise Value to EBIT (EV/EBIT)	11.83	7.80	5.98
Enterprise Value to NOPAT (EV/NOPAT)	16.07	10.17	8.91
Enterprise Value to Operating Cash Flow (EV/OCF)	8.84	6.12	17.44
Enterprise Value to Free Cash Flow (EV/FCFF)	8.73	12.95	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.07	0.15	0.25
Long-Term Debt to Equity	0.04	0.12	0.19
Financial Leverage	-0.02	0.08	0.12
Leverage Ratio	1.40	1.51	1.57
Compound Leverage Factor	1.41	1.47	1.51
Debt to Total Capital	6.34%	13.01%	19.98%
Short-Term Debt to Total Capital	2.26%	2.81%	4.71%
Long-Term Debt to Total Capital	4.07%	10.20%	15.27%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	93.66%	86.99%	80.02%
Debt to EBITDA	0.40	0.60	0.97
Net Debt to EBITDA	-0.40	0.08	0.56
Long-Term Debt to EBITDA	0.26	0.47	0.74
Debt to NOPAT	0.77	0.96	1.75
Net Debt to NOPAT	-0.77	0.13	1.02
Long-Term Debt to NOPAT	0.49	0.75	1.34
Altman Z-Score	5.58	5.29	4.30
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	2.91	2.92	2.85
Quick Ratio	1.03	0.96	1.09
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	68	51	-20
Operating Cash Flow to CapEx	602.66%	329.17%	69.87%
Free Cash Flow to Firm to Interest Expense	30.73	13.03	-6.37
Operating Cash Flow to Interest Expense	30.38	27.57	8.14
Operating Cash Flow Less CapEx to Interest Expense	25.34	19.19	-3.51
Efficiency Ratios	-	-	-
Asset Turnover	1.01	1.14	1.20
Accounts Receivable Turnover	5.44	5.77	5.70
Inventory Turnover	2.90	2.94	3.22
Fixed Asset Turnover	2.95	3.50	3.92
Accounts Payable Turnover	10.13	10.28	9.46
Days Sales Outstanding (DSO)	67.10	63.27	64.02
Days Inventory Outstanding (DIO)	125.94	124.35	113.33
Days Payable Outstanding (DPO)	36.03	35.52	38.60
Cash Conversion Cycle (CCC)	157.01	152.09	138.76
Capital & Investment Metrics	-	-	-
Invested Capital	395	426	412
Invested Capital Turnover	1.45	1.60	1.69
Increase / (Decrease) in Invested Capital	-31	14	72
Enterprise Value (EV)	596	659	456
Market Capitalization	625	650	404
Book Value per Share	$86.23	$85.04	$72.90
Tangible Book Value per Share	$78.81	$76.36	$64.34
Total Capital	451	478	448
Total Debt	29	62	90
Total Long-Term Debt	18	49	68
Net Debt	-29	8.64	52
Capital Expenditures (CapEx)	11	33	37
Debt-free, Cash-free Net Working Capital (DFCFNWC)	160	173	197
Debt-free Net Working Capital (DFNWC)	218	227	234
Net Working Capital (NWC)	207	213	213
Net Nonoperating Expense (NNE)	-0.01	1.39	-3.21
Net Nonoperating Obligations (NNO)	-27	9.94	54
Total Depreciation and Amortization (D&A)	21	19	16
Debt-free, Cash-free Net Working Capital to Revenue	27.01%	25.88%	30.88%
Debt-free Net Working Capital to Revenue	36.65%	33.89%	36.73%
Net Working Capital to Revenue	34.93%	31.88%	33.41%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$7.56	$12.87	$11.03
Adjusted Weighted Average Basic Shares Outstanding	4.91M	4.92M	4.93M
Adjusted Diluted Earnings per Share	$7.50	$12.68	$10.88
Adjusted Weighted Average Diluted Shares Outstanding	4.95M	5.00M	5.00M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	4.94M	4.90M	4.92M
Normalized Net Operating Profit after Tax (NOPAT)	37	65	56
Normalized NOPAT Margin	6.25%	9.67%	8.79%
Pre Tax Income Margin	8.55%	12.30%	11.57%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	22.70	21.62	23.74
NOPAT to Interest Expense	16.70	16.58	15.93
EBIT Less CapEx to Interest Expense	17.66	13.25	12.09
NOPAT Less CapEx to Interest Expense	11.66	8.20	4.28
Payout Ratios	-	-	-
Dividend Payout Ratio	10.98%	6.48%	7.54%
Augmented Payout Ratio	34.17%	36.31%	17.58%

This table displays calculated financial ratios and metrics derived from Preformed Line Products' official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	14.78%	-8.39%	-23.70%	-22.51%	-14.31%	-3.00%	11.22%	31.54%	29.27%	22.18%
EBITDA Growth	76.40%	-36.21%	-49.53%	-48.92%	-60.41%	14.58%	47.76%	89.45%	79.38%	19.58%
EBIT Growth	140.41%	-47.97%	-59.71%	-60.05%	-71.76%	9.98%	53.20%	99.40%	101.47%	27.52%
NOPAT Growth	67.91%	-50.64%	-54.69%	-57.39%	-62.45%	32.32%	50.86%	167.19%	104.21%	15.73%
Net Income Growth	65.56%	-49.18%	-54.23%	-55.17%	-61.74%	27.39%	49.14%	74.12%	84.22%	11.08%
EPS Growth	65.12%	-49.17%	-53.68%	-54.67%	-60.43%	28.39%	47.29%	71.89%	82.12%	9.77%
Operating Cash Flow Growth	24.78%	-77.96%	38.56%	-77.38%	13.25%	177.82%	2,137.92%	591.40%	79.05%	52.61%
Free Cash Flow Firm Growth	651.10%	138.86%	207.32%	149.08%	86.21%	26.69%	-33.85%	30.16%	-94.59%	-120.49%
Invested Capital Growth	-7.31%	-0.74%	-8.40%	-2.23%	3.36%	11.28%	16.95%	16.05%	21.04%	14.85%
Revenue Q/Q Growth	13.71%	5.95%	-1.55%	-3.23%	-9.25%	-11.76%	-0.01%	7.00%	2.73%	1.18%
EBITDA Q/Q Growth	38.38%	-5.12%	-2.23%	37.42%	-49.96%	-24.92%	-1.05%	6.52%	44.81%	-3.19%
EBIT Q/Q Growth	62.44%	-8.14%	-1.82%	64.10%	-64.84%	-28.88%	-2.64%	16.01%	36.91%	-0.93%
NOPAT Q/Q Growth	37.73%	-19.09%	1.24%	48.82%	-59.51%	-25.73%	-4.79%	31.14%	42.68%	-15.33%
Net Income Q/Q Growth	35.72%	-17.84%	-2.46%	52.21%	-58.34%	-25.99%	-4.46%	29.91%	38.68%	-13.35%
EPS Q/Q Growth	38.31%	-18.52%	-2.58%	50.39%	-57.43%	-25.74%	-4.67%	31.29%	38.14%	-14.80%
Operating Cash Flow Q/Q Growth	156.96%	-66.90%	391.81%	-70.17%	-54.62%	108.15%	-19.70%	49.32%	11.32%	1,626.85%
Free Cash Flow Firm Q/Q Growth	285.32%	-76.93%	143.90%	354.24%	72.83%	36.30%	-11.54%	28.58%	-44.47%	-16.30%
Invested Capital Q/Q Growth	-7.06%	4.00%	-5.55%	1.52%	-0.47%	-4.02%	0.81%	7.33%	7.16%	0.87%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	33.29%	31.15%	31.92%	31.32%	33.04%	33.74%	36.48%	36.45%	36.62%	35.24%
EBITDA Margin	13.06%	10.74%	11.99%	12.07%	8.50%	15.42%	18.12%	18.31%	18.40%	13.05%
Operating Margin	10.48%	7.07%	8.14%	8.20%	4.77%	12.51%	15.48%	15.94%	14.47%	10.50%
EBIT Margin	10.16%	7.11%	8.21%	8.23%	4.85%	12.53%	15.54%	15.96%	14.72%	11.05%
Profit (Net Income) Margin	6.25%	5.24%	6.75%	6.82%	4.33%	9.44%	11.26%	11.78%	9.70%	7.19%
Tax Burden Percent	60.30%	73.79%	83.93%	80.98%	90.54%	77.37%	74.30%	75.80%	68.12%	67.57%
Interest Burden Percent	101.98%	99.75%	98.05%	102.28%	98.63%	97.41%	97.47%	97.37%	96.75%	96.30%
Effective Tax Rate	39.70%	26.21%	16.07%	19.02%	9.46%	22.63%	25.70%	24.20%	31.88%	32.43%
Return on Invested Capital (ROIC)	9.14%	7.00%	9.36%	9.55%	6.90%	16.53%	19.43%	19.96%	16.68%	11.81%
ROIC Less NNEP Spread (ROIC-NNEP)	10.47%	7.23%	8.81%	10.15%	6.96%	15.59%	18.50%	19.00%	16.01%	12.18%
Return on Net Nonoperating Assets (RNNOA)	-0.22%	0.21%	0.43%	1.03%	0.57%	1.75%	2.44%	3.06%	1.85%	1.52%
Return on Equity (ROE)	8.92%	7.21%	9.80%	10.58%	7.47%	18.28%	21.87%	23.02%	18.54%	13.33%
Cash Return on Invested Capital (CROIC)	16.63%	8.43%	18.29%	14.18%	12.14%	7.81%	1.61%	0.76%	-5.44%	-2.01%
Operating Return on Assets (OROA)	10.25%	6.79%	8.05%	8.71%	5.55%	15.29%	18.75%	19.11%	17.74%	12.91%
Return on Assets (ROA)	6.31%	5.00%	6.62%	7.21%	4.95%	11.52%	13.58%	14.11%	11.69%	8.40%
Return on Common Equity (ROCE)	8.92%	7.21%	9.80%	10.58%	7.47%	18.28%	21.87%	23.02%	18.54%	13.33%
Return on Equity Simple (ROE_SIMPLE)	0.00%	7.69%	9.71%	12.46%	0.00%	18.39%	17.63%	16.68%	0.00%	14.16%
Net Operating Profit after Tax (NOPAT)	11	7.67	9.48	9.36	6.29	16	21	22	17	12
NOPAT Margin	6.32%	5.22%	6.83%	6.64%	4.32%	9.68%	11.50%	12.08%	9.86%	7.10%
Net Nonoperating Expense Percent (NNEP)	-1.33%	-0.23%	0.55%	-0.60%	-0.06%	0.95%	0.94%	0.96%	0.67%	-0.38%
Return On Investment Capital (ROIC_SIMPLE)	2.34%	-	-	-	1.31%	-	-	-	3.74%	-
Cost of Revenue to Revenue	66.71%	68.85%	68.08%	68.68%	66.96%	66.26%	63.52%	63.55%	63.38%	64.76%
SG&A Expenses to Revenue	11.49%	11.17%	10.99%	11.79%	13.75%	11.09%	10.02%	10.23%	11.53%	10.56%
R&D to Revenue	3.34%	3.77%	3.86%	3.85%	3.91%	3.64%	3.17%	2.86%	2.81%	2.87%
Operating Expenses to Revenue	22.81%	24.08%	23.78%	23.12%	28.26%	21.23%	21.00%	20.52%	22.15%	24.74%
Earnings before Interest and Taxes (EBIT)	17	10	11	12	7.07	20	28	29	25	18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	22	16	17	17	12	25	33	33	31	22
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.48	1.46	1.47	1.52	1.56	1.99	1.93	1.64	1.13	1.05
Price to Tangible Book Value (P/TBV)	1.62	1.61	1.62	1.69	1.74	2.21	2.16	1.85	1.28	1.19
Price to Revenue (P/Rev)	1.05	1.10	1.04	1.00	0.97	1.14	1.10	0.92	0.63	0.58
Price to Earnings (P/E)	16.85	19.06	15.13	12.21	10.26	10.80	10.93	9.85	7.43	7.42
Dividend Yield	0.63%	0.63%	0.64%	0.62%	0.60%	0.50%	0.52%	0.63%	0.97%	1.14%
Earnings Yield	5.94%	5.25%	6.61%	8.19%	9.74%	9.26%	9.15%	10.16%	13.47%	13.48%
Enterprise Value to Invested Capital (EV/IC)	1.51	1.47	1.48	1.50	1.55	1.92	1.83	1.55	1.11	1.04
Enterprise Value to Revenue (EV/Rev)	1.00	1.09	1.03	1.03	0.98	1.18	1.16	1.01	0.72	0.67
Enterprise Value to EBITDA (EV/EBITDA)	8.37	10.08	8.52	7.43	6.37	6.72	6.84	6.33	4.92	5.07
Enterprise Value to EBIT (EV/EBIT)	11.83	15.39	12.02	9.66	7.80	8.02	8.10	7.56	5.98	6.28
Enterprise Value to NOPAT (EV/NOPAT)	16.07	19.00	14.81	12.41	10.17	10.93	11.41	10.67	8.91	9.41
Enterprise Value to Operating Cash Flow (EV/OCF)	8.84	9.94	6.29	7.36	6.12	7.79	10.41	12.08	17.44	21.47
Enterprise Value to Free Cash Flow (EV/FCFF)	8.73	17.33	7.71	10.43	12.95	25.86	121.90	220.54	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.07	0.10	0.09	0.15	0.15	0.18	0.22	0.24	0.25	0.25
Long-Term Debt to Equity	0.04	0.07	0.07	0.13	0.12	0.13	0.17	0.20	0.19	0.19
Financial Leverage	-0.02	0.03	0.05	0.10	0.08	0.11	0.13	0.16	0.12	0.12
Leverage Ratio	1.40	1.45	1.47	1.50	1.51	1.56	1.59	1.60	1.57	1.60
Compound Leverage Factor	1.43	1.44	1.44	1.53	1.49	1.52	1.55	1.56	1.52	1.54
Debt to Total Capital	6.34%	8.96%	8.48%	13.39%	13.01%	15.03%	18.35%	19.52%	19.98%	20.12%
Short-Term Debt to Total Capital	2.26%	2.25%	2.14%	1.79%	2.81%	3.73%	4.22%	3.57%	4.71%	5.09%
Long-Term Debt to Total Capital	4.07%	6.70%	6.34%	11.59%	10.20%	11.30%	14.13%	15.96%	15.27%	15.03%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	93.66%	91.04%	91.52%	86.61%	86.99%	84.96%	81.65%	80.48%	80.02%	79.88%
Debt to EBITDA	0.40	0.68	0.55	0.73	0.60	0.58	0.75	0.85	0.97	1.06
Net Debt to EBITDA	-0.40	-0.09	-0.13	0.21	0.08	0.22	0.39	0.56	0.56	0.66
Long-Term Debt to EBITDA	0.26	0.51	0.41	0.64	0.47	0.44	0.58	0.70	0.74	0.79
Debt to NOPAT	0.77	1.29	0.95	1.23	0.96	0.94	1.26	1.44	1.75	1.96
Net Debt to NOPAT	-0.77	-0.16	-0.22	0.35	0.13	0.36	0.65	0.94	1.02	1.23
Long-Term Debt to NOPAT	0.49	0.96	0.71	1.06	0.75	0.71	0.97	1.17	1.34	1.47
Altman Z-Score	5.39	5.04	5.17	5.03	4.87	5.15	4.90	4.53	4.01	3.89
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.91	2.81	2.93	3.15	2.92	2.49	2.79	2.71	2.85	2.56
Quick Ratio	1.03	0.97	1.43	1.12	0.96	0.93	1.14	1.13	1.09	1.28
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	42	11	47	19	-7.57	-28	-44	-39	-55	-38
Operating Cash Flow to CapEx	693.57%	271.79%	785.94%	844.79%	238.45%	561.92%	231.49%	309.10%	110.51%	134.60%
Free Cash Flow to Firm to Interest Expense	109.50	19.20	82.64	27.18	-10.71	-27.92	-38.57	-36.79	-50.61	-46.40
Operating Cash Flow to Interest Expense	63.17	16.61	49.81	8.13	27.28	42.59	18.01	23.86	15.70	18.68
Operating Cash Flow Less CapEx to Interest Expense	54.06	10.50	43.48	7.16	15.84	35.01	10.23	16.14	1.49	4.80
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.01	0.95	0.98	1.06	1.14	1.22	1.21	1.20	1.20	1.17
Accounts Receivable Turnover	5.44	4.83	4.76	4.98	5.77	5.58	5.22	5.30	5.70	5.18
Inventory Turnover	2.90	2.67	2.72	2.86	2.94	3.13	3.23	3.20	3.22	3.34
Fixed Asset Turnover	2.95	2.84	2.92	3.15	3.50	3.85	3.91	3.86	3.92	3.89
Accounts Payable Turnover	10.13	8.31	8.50	8.49	10.28	8.94	8.98	8.19	9.46	9.37
Days Sales Outstanding (DSO)	67.10	75.56	76.67	73.33	63.27	65.47	69.90	68.88	64.02	70.42
Days Inventory Outstanding (DIO)	125.94	136.84	134.11	127.77	124.35	116.56	112.93	114.15	113.33	109.38
Days Payable Outstanding (DPO)	36.03	43.94	42.96	43.00	35.52	40.83	40.63	44.59	38.60	38.96
Cash Conversion Cycle (CCC)	157.01	168.46	167.83	158.11	152.09	141.19	142.21	138.44	138.76	140.84
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	395	425	409	433	426	428	446	442	412	385
Invested Capital Turnover	1.45	1.34	1.37	1.44	1.60	1.71	1.69	1.65	1.69	1.66
Increase / (Decrease) in Invested Capital	-31	-3.16	-37	-9.89	14	43	65	61	72	50
Enterprise Value (EV)	596	623	603	647	659	821	814	686	456	400
Market Capitalization	625	628	612	629	650	794	768	625	404	348
Book Value per Share	$86.23	$87.30	$84.63	$84.29	$85.04	$81.34	$80.52	$77.39	$72.90	$67.00
Tangible Book Value per Share	$78.81	$79.23	$76.71	$76.04	$76.36	$72.96	$71.79	$68.73	$64.34	$58.89
Total Capital	451	471	455	477	478	471	488	473	448	414
Total Debt	29	42	39	64	62	71	90	92	90	83
Total Long-Term Debt	18	32	29	55	49	53	69	75	68	62
Net Debt	-29	-5.30	-8.85	18	8.64	27	46	61	52	52
Capital Expenditures (CapEx)	3.47	3.45	3.60	0.68	8.09	7.56	8.82	8.23	15	11
Debt-free, Cash-free Net Working Capital (DFCFNWC)	160	170	163	177	173	176	204	199	197	178
Debt-free Net Working Capital (DFNWC)	218	217	211	223	227	220	247	231	234	209
Net Working Capital (NWC)	207	207	201	215	213	202	227	214	213	188
Net Nonoperating Expense (NNE)	0.12	-0.03	0.11	-0.24	-0.02	0.39	0.45	0.55	0.26	-0.15
Net Nonoperating Obligations (NNO)	-27	-4.04	-7.63	19	9.94	28	48	62	54	54
Total Depreciation and Amortization (D&A)	4.85	5.32	5.25	5.41	5.31	4.64	4.69	4.28	6.24	3.31
Debt-free, Cash-free Net Working Capital to Revenue	27.01%	29.67%	27.90%	28.19%	25.88%	25.39%	29.20%	29.24%	30.88%	29.71%
Debt-free Net Working Capital to Revenue	36.65%	37.97%	36.00%	35.49%	33.89%	31.69%	35.37%	33.91%	36.73%	34.89%
Net Working Capital to Revenue	34.93%	36.11%	34.34%	34.12%	31.88%	29.16%	32.43%	31.43%	33.41%	31.36%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.13	$1.57	$1.91	$1.95	$1.32	$3.08	$4.14	$4.33	$3.35	$2.41
Adjusted Weighted Average Basic Shares Outstanding	4.91M	4.90M	4.92M	4.92M	4.92M	4.91M	4.94M	4.94M	4.93M	4.94M
Adjusted Diluted Earnings per Share	$2.13	$1.54	$1.89	$1.94	$1.29	$3.03	$4.08	$4.28	$3.26	$2.36
Adjusted Weighted Average Diluted Shares Outstanding	4.95M	4.98M	4.96M	4.94M	5.00M	4.99M	5.02M	5.00M	5.00M	5.04M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	4.94M	4.90M	4.91M	4.92M	4.90M	4.89M	4.92M	4.95M	4.92M	4.92M
Normalized Net Operating Profit after Tax (NOPAT)	11	7.67	9.48	9.36	6.29	16	21	22	17	16
Normalized NOPAT Margin	6.32%	5.22%	6.83%	6.64%	4.32%	9.68%	11.50%	12.08%	9.86%	9.76%
Pre Tax Income Margin	10.36%	7.10%	8.05%	8.42%	4.79%	12.20%	15.15%	15.54%	14.24%	10.64%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	44.58	18.54	20.04	16.38	9.99	20.14	24.92	27.22	23.06	22.31
NOPAT to Interest Expense	27.72	13.60	16.68	13.22	8.90	15.56	18.44	20.61	15.44	14.33
EBIT Less CapEx to Interest Expense	35.47	12.43	13.70	15.41	-1.45	12.56	17.14	19.51	8.85	8.43
NOPAT Less CapEx to Interest Expense	18.61	7.49	10.35	12.26	-2.54	7.99	10.66	12.89	1.23	0.46
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	10.98%	12.36%	10.09%	7.92%	6.48%	5.63%	5.95%	6.65%	7.54%	8.79%
Augmented Payout Ratio	34.17%	38.89%	47.37%	47.91%	36.31%	32.74%	25.18%	18.32%	17.58%	17.19%

Frequently Asked Questions About Preformed Line Products' Financials

When does Preformed Line Products's financial year end?

According to the most recent income statement we have on file, Preformed Line Products' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Preformed Line Products' net income changed over the last 2 years?

Preformed Line Products' net income appears to be on a downward trend, with a most recent value of $37.11 million in 2024, falling from $54.40 million in 2022. The previous period was $63.34 million in 2023.

What is Preformed Line Products's operating income?

Preformed Line Products's total operating income in 2024 was $50.76 million, based on the following breakdown:

Total Gross Profit: $189.81 million
Total Operating Expenses: $139.05 million

How has Preformed Line Products revenue changed over the last 2 years?

Over the last 2 years, Preformed Line Products' total revenue changed from $637.02 million in 2022 to $593.71 million in 2024, a change of -6.8%.

How much debt does Preformed Line Products have?

Preformed Line Products' total liabilities were at $151.55 million at the end of 2024, a 19.0% decrease from 2023, and a 27.8% decrease since 2022.

How has Preformed Line Products' book value per share changed over the last 2 years?

Over the last 2 years, Preformed Line Products' book value per share changed from 72.90 in 2022 to 86.23 in 2024, a change of 18.3%.

Related Companies

This page (NASDAQ:PLPC) was last updated on 5/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Preformed Line Products (PLPC) Financials

Frequently Asked Questions About Preformed Line Products' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Preformed Line Products (PLPC) Financials

Annual Income Statements for Preformed Line Products

Quarterly Income Statements for Preformed Line Products

Annual Cash Flow Statements for Preformed Line Products

Quarterly Cash Flow Statements for Preformed Line Products

Annual Balance Sheets for Preformed Line Products

Quarterly Balance Sheets for Preformed Line Products

Annual Metrics And Ratios for Preformed Line Products

Quarterly Metrics And Ratios for Preformed Line Products

Frequently Asked Questions About Preformed Line Products' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools